Senior insider sale
SVP, CHIEF OPERATING OFFICER at HALOZYME THERAPEUTICS, INC. — senior position signals high conviction
$1.96M
28.86K shares
What this filing means
CAUDILL CORTNEY plans to sell 28.86K shares of HALOZYME THERAPEUTICS, INC. valued at approximately $1.96M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/10/2026ACC: 0001950047-26-002405
Officer· SVP, CHIEF OPERATING OFFICER
Since Feb 2026
28.86K
Shares to sell
$1.96M
Approx. market value
8.86K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months3
Exercise of options under a registered plan
Cash
3/10/2026
1.55KRestricted stock vesting under a registered plan
Services Rendered
11/1/2025
2.65KRestricted stock vesting under a registered plan
Services Rendered
11/1/2024
4.66KTotal acquired8.86K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/10/2026 | Exercise of options under a registered plan Cash | 1.55K | — |
11/1/2025 | Restricted stock vesting under a registered plan Services Rendered | 2.65K | — |
11/1/2024 | Restricted stock vesting under a registered plan Services Rendered | 4.66K | — |
| Total | 8.86K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
20K
Market value
$1.36M
3/9/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
8.86K
Market value
$599.1K
3/10/2026
Total
Units
28.86K
Value
$1.96M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/9/2026 | 20K | $1.36M | — | Completed |
| Planned — Approximate Date | ||||
3/10/2026 | 8.86K | $599.1K | NASDAQ | Planned |
| Total | 28.86K | $1.96M | ||